Vital Signs - Molecular Diagnostics Market Review: Opportunities in Infectious Diseases, Oncology, Carrier Screening, and Prenatal Testing
Vital Signs - Molecular Diagnostics Market Review: Opportunities in Infectious Diseases, Oncology, Carrier Screening, and Prenatal Testing
RELEASE DATE
05-Jul-2011
05-Jul-2011
REGION
North America
North America
Research Code: 9561-00-CA-00-00
SKU: HC00628-NA-MR_04101
$1,500.00
In stock
SKU
HC00628-NA-MR_04101
Description
This issue of Vital Signs, released on July 6, 2011, provides a strategic insight on the molecular diagnostics market.
Additionally, a company spotlight is provided for Stratos Genomics, a company that is developing a next generation DNA sequencing technology that enables accurate and ultra-low cost whole genome sequencing non-invasive imaging system that provides automated ultrasound images of the human breast. Reimbursement and regulatory news from the FDA is also provided for week of Jun 6, 2011.
Table of Contents
This week's issue
Related Research
Popular Topics
This issue of Vital Signs, released on July 6, 2011, provides a strategic insight on the molecular diagnostics market. Additionally, a company spotlight is provided for Stratos Genomics, a company that is developing a next generation DNA sequencing technology that enables accurate and ultra-low cost whole genome sequencing non-invasive imaging system that provides automated ultrasound images of the human breast. Reimbursement and regulatory news from the FDA is also provided for week of Jun 6, 2011.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-CA-00-00 |
Is Prebook | No |